Repsol (BME:REP) Second Quarter 2024 Results
Key Financial Results
- Revenue: €14.7b (up 13% from 2Q 2023).
- Net income: €657.0m (up 103% from 2Q 2023).
- Profit margin: 4.5% (up from 2.5% in 2Q 2023). The increase in margin was driven by higher revenue.
- EPS: €0.54 (up from €0.24 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Repsol Earnings Insights
Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 1.2% decline forecast for the Oil and Gas industry in Europe.
Performance of the market in Spain.
The company's share price is broadly unchanged from a week ago.
Valuation
Our analysis of Repsol based on 6 different valuation metrics shows it might be undervalued. Click here to find out what a fair price for the stock might be and where analysts see the share price heading over the next year.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About BME:REP
Very undervalued with flawless balance sheet and pays a dividend.